ArTS Archivio della ricerca di Trieste

STOLFO, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.708
EU - Europa 8.407
AS - Asia 7.172
SA - Sud America 973
AF - Africa 233
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 12
Totale 27.525
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.421
IT - Italia 3.736
SG - Singapore 2.605
CN - Cina 1.675
PL - Polonia 1.097
VN - Vietnam 748
BR - Brasile 728
HK - Hong Kong 639
DE - Germania 564
SE - Svezia 551
FR - Francia 413
BD - Bangladesh 378
NL - Olanda 361
KR - Corea 358
GB - Regno Unito 323
RU - Federazione Russa 298
FI - Finlandia 241
IN - India 180
CA - Canada 153
UA - Ucraina 137
IE - Irlanda 132
BG - Bulgaria 128
TR - Turchia 88
MX - Messico 85
JP - Giappone 84
AT - Austria 78
AR - Argentina 74
ES - Italia 71
MA - Marocco 64
ID - Indonesia 55
ZA - Sudafrica 53
CH - Svizzera 49
IQ - Iraq 48
PK - Pakistan 47
BE - Belgio 43
EC - Ecuador 35
CO - Colombia 33
GR - Grecia 30
SA - Arabia Saudita 30
VE - Venezuela 29
CL - Cile 28
RO - Romania 27
EG - Egitto 25
SN - Senegal 25
IR - Iran 24
PE - Perù 24
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
PT - Portogallo 19
PH - Filippine 18
AU - Australia 17
DZ - Algeria 16
JO - Giordania 14
MY - Malesia 14
NP - Nepal 14
CZ - Repubblica Ceca 13
LT - Lituania 13
TW - Taiwan 13
TH - Thailandia 12
HU - Ungheria 11
IL - Israele 11
OM - Oman 11
KE - Kenya 10
KZ - Kazakistan 10
PY - Paraguay 10
CR - Costa Rica 9
LV - Lettonia 9
TN - Tunisia 9
AL - Albania 8
AZ - Azerbaigian 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
RS - Serbia 8
UY - Uruguay 8
EU - Europa 7
JM - Giamaica 7
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
NO - Norvegia 6
TT - Trinidad e Tobago 6
BH - Bahrain 5
BY - Bielorussia 5
LK - Sri Lanka 5
LU - Lussemburgo 5
SY - Repubblica araba siriana 5
BO - Bolivia 4
PA - Panama 4
PS - Palestinian Territory 4
SI - Slovenia 4
TG - Togo 4
CG - Congo 3
CY - Cipro 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
Totale 27.472
Salva come PNG Salva come JPEG
Città #
Ashburn 1.547
Singapore 1.525
Warsaw 938
Fairfield 779
Chandler 746
San Jose 738
Hong Kong 615
Woodbridge 464
Trieste 418
Houston 381
Beijing 367
Milan 354
Seoul 343
Seattle 336
Hefei 335
Ann Arbor 319
Wilmington 287
Council Bluffs 258
Los Angeles 256
Rome 255
Cambridge 245
Ho Chi Minh City 219
Chicago 215
Boardman 202
Dallas 194
New York 173
Naples 165
Princeton 165
Hanoi 158
Santa Clara 152
Lauterbourg 146
Helsinki 138
London 138
Sofia 125
Columbus 124
Jacksonville 124
Dublin 119
Zgierz 119
Frankfurt am Main 108
Moscow 107
The Dalles 98
São Paulo 89
Buffalo 88
Munich 85
Turin 72
Dearborn 62
Amsterdam 61
Tokyo 57
Düsseldorf 53
Toronto 53
Florence 51
Bologna 50
Atlanta 48
Izmir 47
Orem 45
San Diego 45
Vienna 45
Grafing 44
Nuremberg 43
Phoenix 43
Casablanca 42
Da Nang 42
Denver 42
Lappeenranta 42
Montreal 42
Genoa 41
Shanghai 41
Catania 40
Guangzhou 40
Brussels 39
Palermo 37
Washington 35
Bari 34
Chennai 34
Padova 34
Bremen 32
Haiphong 32
Turku 32
Venice 32
Nanjing 31
Verona 31
Memphis 30
Redondo Beach 29
Rio de Janeiro 29
Udine 29
Brooklyn 28
Dong Ket 28
Boston 26
Dakar 25
Des Moines 25
Jinan 25
Johannesburg 25
Miano 25
Mykolayiv 25
Pune 25
Redmond 25
Mumbai 24
Redwood City 24
Bern 23
Stockholm 23
Totale 16.844
Salva come PNG Salva come JPEG
Nome #
Linee guida sullo scompenso cardiaco a confronto: AHA 2022 versus ESC 2021 2.039
Cardiac fluid dynamics meets deformation imaging 480
Natural History of Dilated Cardiomyopathy in Children 434
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 408
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? 407
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 361
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 328
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 325
Left Ventricular Response to Cardiac Resynchronization Therapy: Insights From Hemodynamic Forces Computed by Speckle Tracking 304
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 280
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 277
Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy 274
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 273
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 270
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 267
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 264
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 260
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases 260
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History 259
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 256
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 256
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 256
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure 255
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis 255
Chapter 12: Prognostic Stratification and Importance of Follow-Up 251
Treatment of Functional Mitral Regurgitation in Heart Failure 248
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 247
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 246
Impact of patient delay in a modern real world STEMI network 245
Evolving concepts in dilated cardiomyopathy 239
ECG in dilated cardiomyopathy: Specific findings and long-term prognostic significance 238
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 236
Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature 236
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 234
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy 233
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathyhttps://arts.units.it/submit?resume=115962# 233
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 230
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM 229
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 227
Left Atrial Reverse Remodeling in Dilated Cardiomyopathy 226
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. 226
Chapter 3: Pathophysiology 223
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 222
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 221
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience 220
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 220
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 219
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 215
Coronary fistula of the left main artery draining in the right atrium and associated aorto-right atrial fistula 214
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 214
Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry 212
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 204
Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis 204
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 201
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine 198
Calcific degeneration and rupture of the aortic valve and ascending aorta: From cardiac auscultation to multimodality imaging 191
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 186
Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 185
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 183
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 183
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 181
Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives 180
Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation 180
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy 180
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 179
Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction 177
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 175
Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences 174
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 171
Prognostic significance of longitudinal strain in dilated cardiomyopathy with recovered ejection fraction 171
Does extracorporeal cardiopulmonary resuscitation improve survival with favorable neurological outcome in out-of-hospital cardiac arrest? A systematic review and meta-analysis 169
Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications 167
Dilated cardiomyopathy: Dilated cardiomyopathy: Clinical assessment and differential diagnosis 167
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 164
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 163
Effect of prehospital treatment in STEMI patients undergoing primary PCI 163
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 161
Value of Strain Imaging and Maximal Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy 158
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 156
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation 156
Impaired Right Ventricular Longitudinal Strain Without Pulmonary Hypertension in Patients Who Have Recovered From COVID-19 155
Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy 155
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 154
Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry. 152
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients 152
Using marginal structural joint models to estimate the effect of a time-varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy 149
Heart failure with mid-range or mildly reduced ejection fraction 149
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 146
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis 145
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 144
A very rare cause of pre-capillary pulmonary hypertension: The PAMI syndrome 144
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 141
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring with Arrhythmic Risk in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy 141
Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications 137
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension 135
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator 135
The Arrhythmic Phenotype in Cardiomyopathy 134
In-hospital evolution of secondary mitral regurgitation in acutely decompensated heart failure 133
Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis 133
Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathy 133
Totale 23.246
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.394
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.352 67 82 67 75 85 125 63 43 137 142 136 330
2022/20233.242 188 291 294 420 270 415 151 291 314 150 287 171
2023/20242.484 204 161 169 220 213 266 390 303 63 108 242 145
2024/20254.565 113 207 385 397 406 354 233 262 577 674 446 511
2025/202611.369 1.090 672 807 1.073 956 884 1.413 416 1.167 1.458 880 553
2026/202728 28 0 0 0 0 0 0 0 0 0 0 0
Totale 28.259